Company news
Helix BioPharma Corp. news in 2006
Helix BioPharma Corp.'s news releases, calls and decks from 2006, newest first.
Helix BioPharma Corp. responds to Penta
December 22, 2006
Helix Biopharma announces Q1 2007 financial results
December 13, 2006
Helix BioPharma Corp. initiates enrollment in Phase II clinical trial with Topical Interferon Alpha-2b in patients with ano-genital warts
December 11, 2006
Helix BioPharma Corp. announces change of date and type of meeting for Annual General Meeting
December 8, 2006
Helix Biopharma Corp. completes Phase 2 clinical study with Topical Interferon Alpha-2B in patients with low-grade squamous intraepithelial lesions
November 14, 2006
Helix BioPharma Corp. announces fiscal 2006 results
October 26, 2006
Helix BioPharma to present L-DOS47 lung cancer research findings at Zurich conference
June 26, 2006
Helix BioPharma announces Q3 2006 financial results
June 7, 2006
Helix retains leading health care communications firm
June 5, 2006
Helix BioPharma announces Q2 2006 financial results
March 14, 2006
Helix receives milestone payment on biochip license
February 10, 2006
Helix BioPharma signs agreement with the National Research Council of Canada
January 31, 2006